Margareta Elisabeth Björk
Director/Board Member at PHARVARIS N.V.
Net worth: 503 080 $ as of 2024-04-29
Margareta Elisabeth Björk active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 2012-05-31 | - |
| ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 2020-04-19 | - |
| Independent Dir/Board Member | 2020-04-19 | - | |
| PHARVARIS N.V. | Director/Board Member | 2021-11-30 | - |
| Independent Dir/Board Member | 2021-11-30 | - | |
| CALLIDITAS THERAPEUTICS AB | Director/Board Member | 2021-12-31 | - |
| Independent Dir/Board Member | 2021-12-31 | - | |
| VICORE PHARMA HOLDING AB | Director/Board Member | 2022-12-31 | - |
| University of Uppsala | Corporate Officer/Principal | - | - |
| Chalmers University of Technology | Director/Board Member | - | - |
| Björks Matematik o Mera AB | Director/Board Member | - | - |
| Rfidcompare Europe AB | Director/Board Member | - | - |
Career history of Margareta Elisabeth Björk
Former positions of Margareta Elisabeth Björk
| Companies | Position | Start | End |
|---|---|---|---|
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Margareta Elisabeth Björk
| Karolinska Institutet | Doctorate Degree |
| University of Uppsala | Doctorate Degree |
Statistics
International
| Sweden | 9 |
| United Kingdom | 3 |
| Netherlands | 2 |
Operational
| Director/Board Member | 8 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 3 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 4 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| VICORE PHARMA HOLDING AB | Health Technology |
| PHARVARIS N.V. | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Health Technology |
Uppsala University Hospital
 Uppsala University Hospital Hospital/Nursing ManagementHealth Services Uppsala University Hospital operates a hospital. | Health Services |
| Björks Matematik o Mera AB | |
| Rfidcompare Europe AB |
